HUTCHMED (China) (HCM) Receivables (2016 - 2025)
HUTCHMED (China) (HCM) has disclosed Receivables for 11 consecutive years, with $148.5 million as the latest value for Q4 2025.
- On a quarterly basis, Receivables fell 6.16% to $148.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $148.5 million, a 6.16% decrease, with the full-year FY2025 number at $148.5 million, down 6.16% from a year prior.
- Receivables was $148.5 million for Q4 2025 at HUTCHMED (China), down from $158.3 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $158.3 million in Q4 2024 to a low of $84.7 million in Q4 2021.
- A 5-year average of $137.6 million and a median of $148.5 million in 2025 define the central range for Receivables.
- Peak YoY movement for Receivables: surged 78.46% in 2022, then fell 6.16% in 2025.
- HUTCHMED (China)'s Receivables stood at $84.7 million in 2021, then soared by 78.46% to $151.2 million in 2022, then decreased by 3.87% to $145.4 million in 2023, then grew by 8.89% to $158.3 million in 2024, then decreased by 6.16% to $148.5 million in 2025.
- Per Business Quant, the three most recent readings for HCM's Receivables are $148.5 million (Q4 2025), $158.3 million (Q4 2024), and $145.4 million (Q4 2023).